Bo Rothstein, one of the most influential political scientists in the world today, explains how countries can become less corrupt, and why the Nordic model is successful. The first of a two-part interview.
Read more
“It’s Difficult to Produce Good Policy in Thin Political Markets”
Harvard Business School’s Karthik Ramanna, author of Political Standards, outlines the potential harms of thin political markets and offers ways to mitigate capture. “It’s difficult to produce good policy in thin political markets if you accept the normative implications of the current economic theory of the firm.”
Read more
“There Is Regulatory Capture, But It Is By No Means Complete”
Kenneth J. Arrow, one of the most influential economists of the 20th century, reflects on the benefits of a single payer health care system, the role of government and regulatory capture.
Read more
The Insider’s Guide to the Regulatory Game: Anonymous Source in the Pharma Industry in a Series of Columns on the Inner Workings of the Industry
Sitting across the table from me was Brad (not his real name), a top sales representative at a large pharmaceutical company. I asked him about the receipts for over $2000 in gift certificates to a Michelin star restaurant, expensed to the company, that were lying on the table.
Read more
Stigler Fellow of the Month: Beyond the Traditional Capture Theory
Harvard Business School’s Rafael Di Tella is “Stigler Fellow of the Month“. He talks about how any theory of regulation should consider the roles that media, threats and public opinion play.
Read more
From Mancur Olson to Bernie Sanders
Professor George Stigler, the Nobel Laureate (1982) who in some ways invented the idea of “regulatory capture,” and Professor Mancur Olson, who developed some of the most important ideas of “public choice,” are not around anymore. If they were alive today, they would probably be surprised to learn that the first politician in recent U.S. history to take their advice seriously and challenge them is a self-described socialist.
Read more
“Capture is Everywhere – It Happens at the Highest Levels of Our Democracy”
Armed with research on drug patents and a spate of internal emails from the United States Patent and Trademark Office, hedge fund manager Kyle Bass attacks pharma regulation.
Read more